This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Stage I Ovarian Borderline Tumor

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

Understanding Stage I Ovarian Borderline Tumor

Stage I Ovarian Borderline Tumor is a type of growth found in the ovaries or fallopian tubes, which are part of the female reproductive system. Unlike typical ovarian cancer, this tumor has abnormal cells that do not clearly behave like cancer cells but have the potential to become cancerous. The term “Stage I” means the tumor is limited to one or both ovaries or fallopian tubes and has not spread to other parts of the body. This stage is further divided into IA, IB, and IC based on whether the tumor is in one ovary or both, and whether the tumor or its outer covering has ruptured or spread cells within the pelvic cavity.

Why Knowing the Stage Matters

Knowing the stage of the tumor helps doctors plan the best treatment and understand the likely outcome. Stage I tumors are usually found early and tend to have a better prognosis compared to more advanced stages. The exact treatment depends on factors like tumor size, whether it involves part or all of the ovary, the type of cells involved, and the patient’s overall health and wishes about fertility. Because these tumors often grow slowly and may not spread quickly, many patients have a good chance of recovery.

Signs, Symptoms, and Diagnosis

Some people with Stage I Ovarian Borderline Tumor may notice pain or swelling in the abdomen or pelvis. Others might experience digestive symptoms like bloating, gas, or constipation. However, early tumors often cause no symptoms, so they may be found during routine exams or imaging tests. To diagnose and stage the tumor, doctors perform pelvic exams, ultrasounds (including transvaginal ultrasound), and sometimes other imaging or lab tests. These help determine the tumor’s size, location, and whether it has spread.

Where You Might Encounter This Term

You may see “Stage I Ovarian Borderline Tumor” or “Stage I Ovarian Low Malignant Potential Tumor” in medical reports, pathology results, treatment plans, or discussions with your care team. These terms refer to the same condition, so comparing wording can help avoid confusion. Understanding this term can help you ask informed questions about your diagnosis and treatment options.

What This Term Does Not Mean

Having a Stage I Ovarian Borderline Tumor does not automatically mean you have invasive ovarian cancer. These tumors are different because they usually do not spread quickly or deeply invade tissues. Also, the presence of this tumor does not guarantee symptoms or immediate health problems. It is important not to assume the worst but to discuss your specific case with your doctor.

Questions to Ask Your Care Team

You might want to ask about the exact stage and subtype of your tumor, what treatment options are recommended, and how the tumor might affect your fertility or overall health. It is also reasonable to ask about the need for second opinions, follow-up tests, and what signs or symptoms to watch for. Understanding your prognosis and what to expect can help you feel more in control of your care.

Using This Information Safely

This information is meant to help you understand the term “Stage I Ovarian Borderline Tumor” but cannot replace personalized medical advice. Every patient’s situation is unique, so it is important to discuss your diagnosis and treatment plan with your healthcare providers. They can explain what this term means for you specifically and guide you through your care.

Next Steps After Learning This Term

If you or a loved one has been told about a Stage I Ovarian Borderline Tumor, the next sensible step is to talk openly with your care team. Ask for clear explanations, consider getting a second opinion if you wish, and discuss your treatment options and follow-up plan. Early detection and careful management often lead to good outcomes with this condition.

Sources

Public source information used for this glossary entry includes: